Literature DB >> 6180520

Allo-antibodies to an antigenic determinant shared by HLA-A2 and B17.

F Claas, R Castelli-Visser, I Schreuder, J van Rood.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6180520     DOI: 10.1111/j.1399-0039.1982.tb01465.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


× No keyword cloud information.
  5 in total

1.  Interaction between des-Tyr1-gamma-endorphin and HLA class I molecules: serological detection of an HLA-A2 subtype.

Authors:  F H Claas; J J van der Poel; R Castelli-Visser; J Pool; R B Chen; K Y Xu; J J van Rood
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

2.  Epstein-Barr virus-specific cytotoxic T lymphocytes as probes of HLA polymorphism. Heterogeneity of T cell-restricting determinants associated with the serologically defined HLA-A2 antigen.

Authors:  J S Gaston; A B Rickinson; M A Epstein
Journal:  J Exp Med       Date:  1983-08-01       Impact factor: 14.307

3.  Human Leukocyte Antigen-Based Risk Stratification in Heart Transplant Recipients-Implications for Targeted Surveillance.

Authors:  Johan Nilsson; David Ansari; Mattias Ohlsson; Peter Höglund; Ann-Sofie Liedberg; J Gustav Smith; Pierre Nugues; Bodil Andersson
Journal:  J Am Heart Assoc       Date:  2019-07-24       Impact factor: 5.501

Review 4.  The long and winding road towards epitope matching in clinical transplantation.

Authors:  Cynthia S M Kramer; Moshe Israeli; Arend Mulder; Ilias I N Doxiadis; Geert W Haasnoot; Sebastiaan Heidt; Frans H J Claas
Journal:  Transpl Int       Date:  2018-11-26       Impact factor: 3.782

5.  HLA-EMMA: A user-friendly tool to analyse HLA class I and class II compatibility on the amino acid level.

Authors:  Cynthia S M Kramer; Johan Koster; Geert W Haasnoot; Dave L Roelen; Frans H J Claas; Sebastiaan Heidt
Journal:  HLA       Date:  2020-04-13       Impact factor: 4.513

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.